Comprehensive imaging of residual/recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT

European Radiology

Volumn 20, Issue 9, 2010, Pages 2229-2240

  Ng, Shu Hang ^a,b   Chan, Sheng Chieh ^a   Yen, Tzu Chen ^a   Liao, Chun Ta ^a   Chang, Joseph Tung Chieh ^a   Ko, Sheung Fat ^a,b   Wang, Hung Ming ^a   Lin, Chin Yu ^a   Chang, Kai Ping ^a   Lin, Yu Chun ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Computed tomography; Magnetic resonance imaging; Positron emission tomography; Recurrent nasopharyngeal carcinoma; Whole body

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL EVALUATION; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY; WHOLE BODY MRI;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 77957946418     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-010-1784-9     Document Type: Article

References (46)

1. Koshy M, Paulino AC, Howell R, Schuster D, Halkar R, Davis LW (2005) F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer. Head Neck 27:494-502
2. Zheng XK, Chen LH, Wang QS, Wu FB (2006) Influence of [18F] fluorodeoxyglucose positron emission tomography on salvage treatment decision making for locally persistent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 65:1020-1025
3. Low JS, Chua ET, Gao F, Wee JT (2006) Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinoma. Head Neck 28:321-329
4. Chen MY, Guo X, Wen WP et al (2007) Salvage surgical operation via endoscopic transnasal approach for local persistent or recurrent nasopharyngeal carcinoma. Ai Zheng 26:673-678
5. Yen TC, Lin CY, Wang HM et al (2006) 18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 65:1307-1314
6. Manavis J, Sivridis L, Koukourakis MI (2005) Nasopharyngeal carcinoma: the impact of CT-scan and of MRI on staging, radiotherapy treatment planning, and outcome of the disease. Clin Imaging 29:128-133
7. Chong VF, Fan YF (1997) Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT. Radiology 202:463-470
8. Ng SH, Chang JT, Ko SF, Wan YL, Tang LM, Chen WC (1999) MRI in recurrent nasopharyngeal carcinoma. Neuroradiology 41:855-862
9. Ng SH, Liu HM, Ko SF, Hao SP, Chong VF (2002) Posttreatment imaging of the nasopharynx. Eur J Radiol 44:82-95
10. Ng SH, Wan YL, Ko SF, Chang JT (1998) MRI of nasopharyngeal carcinoma with emphasis on relationship to radiotherapy. J Magn Reson Imaging 8:327-336
11. Olmi P, Fallai C, Colagrande S, Giannardi G (1995) Staging and followup of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography. Int J Radiat Oncol Biol Phys 32:795-800
12. Chan SC, Ng SH, Chang JT et al (2006) Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging. Eur J Nucl Med Mol Imaging 33:1032-1040
13. Liu T, Xu W, Yan WL, Ye M, Bai YR, Huang G (2007) FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review. Radiother Oncol 85:327-335
14. Yen RF, Hung RL, Pan MH et al (2003) 18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging. Cancer 98:283-287
15. Chan SC, Yen TC, Ng SH et al (2006) Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management. J Nucl Med 47:1447-1454
16. Yen RF, Hong RL, Tzen KY, Pan MH, Chen TH (2005) Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma. J Nucl Med 46:770-774
17. Ng SH, Joseph CT, Chan SC et al (2004) Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. J Nucl Med 45:1669-1676
18. Comoretto M, Balestreri L, Borsatti E, Cimitan M, Franchin G, Lise M (2008) Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT. Radiology 249:203-211
19. Wang GH, Lau EW, Shakher R et al (2007) Clinical application of (18) F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma. Ai Zheng 26:638-642
20. Yu DF, Zuo CT, Dai JZ et al (2004) Application of 18F-FDG PET/CT scan in following-up of nasopharyngeal carcinoma after radiotherapy. Ai Zheng 23:1538-1541
21. Walker RE, Eustace SJ (2001) Wholebody magnetic resonance imaging: techniques, clinical indications, and future applications. Semin Musculoskelet Radiol 5:5-20
22. Schick F (2005) Whole-body MRI at high field: technical limits and clinical potential. Eur Radiol 15:946-959
23. Lauenstein TC, Goehde SC, Herborn CU et al (2004) Whole-body MR imaging: evaluation of patients for metastases. Radiology 233:139-148
24. Schmidt GP, Wintersperger B, Graser A, Baur-Melnyk A, Reiser MF, Schoenberg SO (2007) High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study. Invest Radiol 42:449-459
25. Willinek WA, Schild HH (2008) Clinical advantages of 3.0 T MRI over 1.5 T. Eur J Radiol 65:2-14
26. Schmidt GP, Baur-Melnyk A, Haug A et al (2009) Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol 19:1366-1378
27. Schmidt GP, Baur-Melnyk A, Haug A et al (2008) Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT. Eur J Radiol 65:47-58
28. van den Brekel MW, Stel HV, Castelijns JA et al (1990) Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 177:379-384
29. Ng SH, Chang JT, Chan SC et al (2004) Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Eur J Nucl Med Mol Imaging 31:1073-1080
30. Lam WW, Chan YL, Leung SF, Metreweli C (1997) Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma. Head Neck 19:176-181
31. Ng SH, Ko SF, Toh CH, Chen YL (2006) Imaging of neck metastases. Chang Gung Med J 29:119-129
32. Metz CE (1986) ROC methodology in radiologic imaging. Invest Radiol 21:720-733
33. Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839-843
34. Sham JS, Wei WI, Kwan WH, Chan CW, Kwong WK, Choy D (1990) Nasopharyngeal carcinoma. Pattern of tumor regression after radiotherapy. Cancer 65:216-220
35. Fujii M, Kanzaki J (1994) The role of MRI for the diagnosis of recurrence of nasopharyngeal cancer. Auris Nasus Larynx 21:32-37
36. Gong QY, Zheng GL, Zhu HY (1991) MRI differentiation of recurrent nasopharyngeal carcinoma from postradiation fibrosis. Comput Med Imaging Graph 15:423-429
37. Pfannenberg C, Aschoff P, Schanz S et al (2007) Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer 43:557-564
38. Antoch G, Vogt FM, Freudenberg LS et al (2003) Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290:3199-3206
39. Yi CA, Shin KM, Lee KS et al (2008) Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. Radiology 248:632-642
40. Lauenstein TC, Goehde SC, Herborn CU et al (2002) Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 minutes: a feasibility study. AJR Am J Roentgenol 179:445-449
41. Vogt FM, Herborn CU, Hunold P et al (2004) HASTE MRI versus chest radiography in the detection of pulmonary nodules: comparison with MDCT. AJR Am J Roentgenol 183:71-78
42. Frericks BB, Meyer BC, Martus P, Wendt M, Wolf KJ, Wacker F (2008) MRI of the thorax during whole-body MRI: evaluation of different MR sequences and comparison to thoracic multidetector computed tomography (MDCT). J Magn Reson Imaging 27:538-545
43. Schmidt GP, Haug AR, Schoenberg SO, Reiser MF (2006) Whole-body MRI and PET-CT in the management of cancer patients. Eur Radiol 16:1216-1225
44. Ngan RK, Yiu HH, Cheng HK, Chan JK, Sin VC, Lau WH (2002) Central nervous system metastasis from nasopharyngeal carcinoma: a report of two patients and a review of the literature. Cancer 94:398-405
45. Gollub MJ, Hong R, Sarasohn DM, Akhurst T (2007) Limitations of CT during PET/CT. J Nucl Med 48:1583-1591
46. Yoshida K, Suzuki A, Nagashima T et al (2009) Staging primary head and neck cancers with (18) F-FDG PET/CT: is intravenous contrast administration really necessary? Eur J Nucl Med Mol Imaging 36:1417-1424